Table 2.
Antibiotic resistance genes (ARGs) of the studied bacterial strains.
| Antibiotics | Target Genes | CMU | CMS1 | Lr | Ls | Lrh | Ef |
|---|---|---|---|---|---|---|---|
| GEN | aac(6′)-aph(2”) | - | - | - | - | - | - |
| aac(6′)Ie-aph(2”)La | - | - | - | - | - | - | |
| CHL | catA | - | - | - | - | - | - |
| cat | - | - | - | - | - | - | |
| STR | aadA | - | - | - | - | - | - |
| aadE | - | - | - | - | - | - | |
| ant(6) | - | - | - | - | - | - | |
| dfrD | - | - | - | - | - | - | |
| VAN | vanE | - | - | - | - | - | - |
| vanX | - | - | - | - | - | - | |
| AMP | blaZ | - | - | - | - | - | - |
| bla | - | - | - | - | - | - | |
| mecA | - | - | - | - | - | - | |
| TET | tet(M) | - | - | - | - | - | + |
| tet(K) | - | - | - | - | - | - | |
| tet(W) | - | - | - | - | - | - | |
| RIF | rpoB | - | - | - | - | - | - |
| KAN | aph(3”)-III | - | - | - | - | - | - |
| ant(2”)-I | - | - | - | - | - | - | |
| aph(3”)-I | - | - | - | - | - | - | |
| CIP | gyrA | - | - | - | - | - | - |
| parC | - | - | - | - | - | - | |
| CLIN | lnu(A) | - | - | - | - | - | - |
| lnu(B) | - | - | - | - | - | - | |
| ERY | erm(B) | - | - | - | - | - | - |
| erm(B)-1 | - | - | - | - | - | - | |
| erm(C) | - | - | - | - | - | - | |
| LIN | cfr | - | - | - | - | - | - |
| Conjugative transposon integrons | Tn916/Tn1545 | - | - | - | - | - | + |
GEN, gentamicin; CHL, chloramphenicol; STR, streptomycin; VAN, vancomycin; AMP, ampicillin; TET, tetracycline; RIF, rifampicin; KAN, kanamycin; CIP, ciprofloxacin; CLIN, clindamycin; ERY, erythromycin; and LIN, linezolid. CMU, W. cibaria CMU; CMS1, W. cibaria CMS1; Lr, L. reuteri isolated from a commercial product (Sweden); Ls, L. salivarius isolated from a commercial product (Japan); Lrh, L. rhamnosus GG (KCTC 5033); and Ef, E. faecalis ATCC 29212.